Characteristics | N (%) | P value | ||
---|---|---|---|---|
 | Total | Low IDO2 scores | High IDO2 scores |  |
Gender | Â | Â | Â | 0.017 * |
Male | 85(45.5) | 42(49.4) | 43(50.6) | Â |
Female | 102(54.5) | 68(66.7) | 34(33.3) | Â |
Age at surgery(year) | Â | Â | Â | 0.472 |
≤ 52 | 101(54.0) | 57(56.4) | 44(43.6) |  |
>52 | 86(46.0) | 53(61.6) | 33(38.4) | Â |
Heredity | Â | Â | Â | 0.582 |
Hereditary | 33(17.6) | 18(54.5) | 15(45.5) | Â |
sporadic | 154(82.4) | 92(59.7) | 62(40.3) | Â |
Multifocal | Â | Â | Â | 0.038 * |
Yes | 55(29.4) | 26(47.3) | 29(52.7) | Â |
No | 132(70.6) | 84(63.6) | 48(36.4) | Â |
ETE | Â | Â | Â | 0.020 * |
Yes | 76(40.6) | 37(48.7) | 39(51.3) | Â |
No | 111(59.4) | 73(65.8) | 38(34.2) | Â |
Bilateral lesions | Â | Â | Â | 0.184 |
Yes | 20(10.7) | 9(45%) | 11(55%) | Â |
No | 167(89.3) | 101(60.5) | 66(39.5) | Â |
Tumor size(cm) | Â | Â | Â | 0.716 |
≤ 2 | 120(64.2) | 73(60.8) | 47(39.2) |  |
2–4 | 57(30.5) | 31(54.4) | 26(45.6) |  |
>4 | 10(5.3) | 6(60.0) | 4(40.0) | Â |
pT stage | Â | Â | Â | 0.004 * |
T1/T2 | 108(57.7) | 73(67.6) | 35(32.4) | Â |
T3/T4 | 79(42.3) | 37(46.8) | 42(53.2) | Â |
pN stage | Â | Â | Â | <0.001 * |
N0 | 87(46.5) | 73(83.9) | 14(16.1) | Â |
N1a | 26(13.9) | 10(38.5) | 16(61.5) | Â |
N1b | 74(39.6) | 27(36.5) | 47(63.5) | Â |
8th TNM stage | Â | Â | Â | <0.001 * |
I/II | 77(41.1) | 63(81.8) | 14(18.2) | Â |
III/IV | 110(58.9) | 47(42.7) | 63(57.3) | Â |
Coexist HT | Â | Â | Â | 0.403 |
Yes | 24(12.8) | 16(66.7) | 8(33.3) | Â |
No | 163(87.2) | 94(57.7) | 69(42.3) | Â |
Pathology | Â | Â | Â | 0.319 |
Only MTC | 105(56.1) | 58(55.2) | 47(44.8) | Â |
With adenomatous goiter | 9(4.8) | 6(66.7) | 3(33.3) | Â |
With nodular goiter | 51(27.3) | 35(68.6) | 16(31.4) | Â |
With PTC | 22(11.8) | 11(50.0) | 11(50.0) | Â |
Recurrence | Â | Â | Â | 0.023 * |
Yes | 22(11.8) | 8(36.4) | 14(63.6) | Â |
No | 165(88.2) | 102(61.8) | 63(38.2) | Â |
Biochemical cure | Â | Â | Â | 0.002 * |
Yes | 98(52.4) | 68(69.4) | 30(30.6) | Â |
No | 89(47.6) | 42(47.2) | 47(52.8) | Â |